{"id":"https://openalex.org/W2018644937","doi":"https://doi.org/10.1007/bf00233243","title":"Characteristics of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes","display_name":"Characteristics of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes","publication_year":1995,"publication_date":"1995-03-01","ids":{"openalex":"https://openalex.org/W2018644937","doi":"https://doi.org/10.1007/bf00233243","mag":"2018644937","pmid":"https://pubmed.ncbi.nlm.nih.gov/7609777"},"language":"en","primary_location":{"id":"doi:10.1007/bf00233243","doi":"https://doi.org/10.1007/bf00233243","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00233243","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037866444","display_name":"Makoto Tanaka","orcid":"https://orcid.org/0000-0002-1826-3111","observed_orcids":["https://orcid.org/0000-0002-1826-3111"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Tanaka","raw_affiliation_strings":["Department of Pharmacology, Taisho Pharmaceutical Co., Ltd., Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Taisho Pharmaceutical Co., Ltd., Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038934637","display_name":"Takayoshi Shirasaki","orcid":"https://orcid.org/0000-0001-9756-8935","observed_orcids":["https://orcid.org/0000-0001-9756-8935"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T. Shirasaki","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, 330, Ohmiya, Saitama, Japan","Department of Pharmacology Research Center, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, 330, Ohmiya, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Department of Pharmacology Research Center, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055851227","display_name":"Shinsuke Kaku","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"S. Kaku","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, 330, Ohmiya, Saitama, Japan","Department of Pharmacology Research Center, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, 330, Ohmiya, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Department of Pharmacology Research Center, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100884750","display_name":"Makoto Muramatsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Muramatsu","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, 330, Ohmiya, Saitama, Japan","Department of Pharmacology Research Center, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, 330, Ohmiya, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Department of Pharmacology Research Center, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111768033","display_name":"Susumo Otomo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"S. Otomo","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, 330, Ohmiya, Saitama, Japan","Department of Pharmacology Research Center, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, 330, Ohmiya, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Department of Pharmacology Research Center, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I144245601"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":2.1268,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.85714286,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"351","issue":"3","first_page":"244","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ne-100","display_name":"NE-100","score":0.8809999823570251},{"id":"https://openalex.org/keywords/sigma-receptor-ligands","display_name":"sigma receptor ligands","score":0.6959999799728394},{"id":"https://openalex.org/keywords/sigma-1-receptor","display_name":"sigma-1 receptor","score":0.8759999871253967},{"id":"https://openalex.org/keywords/receptor-binding","display_name":"receptor binding","score":0.5569999814033508},{"id":"https://openalex.org/keywords/subcellular-localization","display_name":"subcellular localization","score":0.7089999914169312},{"id":"https://openalex.org/keywords/cerebellum","display_name":"cerebellum","score":0.9089999794960022},{"id":"https://openalex.org/keywords/medulla-oblongata","display_name":"medulla oblongata","score":0.9940000176429749},{"id":"https://openalex.org/keywords/microsomes","display_name":"microsomes","score":0.6650000214576721},{"id":"https://openalex.org/keywords/receptor-antagonists","display_name":"receptor antagonists","score":0.36000001430511475}],"concepts":[{"id":"https://openalex.org/C2778815084","wikidata":"https://www.wikidata.org/wiki/Q79803","display_name":"Guinea pig","level":2,"score":0.7775460481643677},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.7013578414916992},{"id":"https://openalex.org/C2777052854","wikidata":"https://www.wikidata.org/wiki/Q7512419","display_name":"Sigma receptor","level":3,"score":0.6823484897613525},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.6176052093505859},{"id":"https://openalex.org/C2778049214","wikidata":"https://www.wikidata.org/wiki/Q7512234","display_name":"Sigma","level":2,"score":0.5692008137702942},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5445584654808044},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47899338603019714},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.4132230281829834},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.35022062063217163},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.33017081022262573},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2785325050354004},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27076956629753113},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.24699068069458008},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.12863454222679138},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000840","descriptor_name":"Anisoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008566","descriptor_name":"Membranes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009711","descriptor_name":"Nucleotides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013347","descriptor_name":"Subcellular Fractions","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf00233243","doi":"https://doi.org/10.1007/bf00233243","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00233243","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},{"id":"pmid:7609777","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7609777","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's archives of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1623883571","https://openalex.org/W1775749144","https://openalex.org/W1883742294","https://openalex.org/W1886668162","https://openalex.org/W1900414416","https://openalex.org/W1973750932","https://openalex.org/W1989434444","https://openalex.org/W1992763610","https://openalex.org/W1992768650","https://openalex.org/W1996137477","https://openalex.org/W2007072878","https://openalex.org/W2008670721","https://openalex.org/W2015205324","https://openalex.org/W2021441138","https://openalex.org/W2036517215","https://openalex.org/W2036777870","https://openalex.org/W2037351445","https://openalex.org/W2045254485","https://openalex.org/W2046130678","https://openalex.org/W2050563394","https://openalex.org/W2050995681","https://openalex.org/W2061633232","https://openalex.org/W2071652654","https://openalex.org/W2072773847","https://openalex.org/W2074631079","https://openalex.org/W2089108699","https://openalex.org/W2091253738","https://openalex.org/W2105541592","https://openalex.org/W2128754068","https://openalex.org/W2140839880","https://openalex.org/W2148418924","https://openalex.org/W2158767242","https://openalex.org/W2196594876","https://openalex.org/W2243537211","https://openalex.org/W2307484198","https://openalex.org/W2415625347","https://openalex.org/W2416392089"],"related_works":["https://openalex.org/W2050563394","https://openalex.org/W1997361789","https://openalex.org/W2082451747","https://openalex.org/W3105855494","https://openalex.org/W2015205324","https://openalex.org/W1969959851","https://openalex.org/W1987258940","https://openalex.org/W2013164642","https://openalex.org/W2016190141","https://openalex.org/W4256483912"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}